可溶性メソテリン関連ペプチドキット 全般的な注意 形状
Contents
1. G1200 1 3 1 4 3 4 1 0 0 1 2 jt2. 3 No 219799 4 2 X 2 294192 1 4 X3 Sa 219805 Sa 294208 3 X 219973 100mLX6 292600 50mLXx6 219942 1000mLX1 219935
3. SMR PP 2 2 1 l 4 SMR P 100nmo 1 5
4. 200gL 37 5 a 47 7nm AM LA RS P SMR P SMR P 1 0 1 1 2 3
5. 1 1 HIV HBV HCV 2 3 p H 1 0 4 2 1 2
6. 0 2 0 CV 1 0 H F 3 SD 003nmo1 0 1 nmo 1 r 0 99 3 SMR P 7 Lo E 9 Il 106 n 10 6 y1 02x 0 01 x S MR P 2 4 136 4 2 6
7. 1 9 6 E MD 1 5 1 4 ll 1 5nmo 1 L L 9 0 fi 1 0 Onm 2 5 1 2 85 240 157 136 74 110 56 51 24 24 7 1 5nmol L 66 2196 15 18 9 19 36 12 3 0nmol L 42 5 0 196 096 21 5 0nmol L 259
8. 7 8 9 10 11 ALP 12 F
9. 4 0 5 6 OO 10mg mL 38mg mL 100U mL 100U mL 1 0 2 F C 19 7mg d 21 8mg d 487mg dL 1 8 9 0 5 0 0 IU mL
10. 2 2 10C 2 10 C 2 10C 6 2 10C 1 2 10 C 2 10 C 2 10C E 0 05 NE 000ppm 1 1 2 1 2 0 1 5 1000ppm 1 6 3 2 1 4 1 4 1 1 9 9 9
11. 5 SMRP 8 0 2 0 SE 1 1 5 13 1 1 6 0 3 49 8 6 6 10 2 4 157 1 6 5 6 7 0 HE 9 i
12. tS itute Nathalie Scholler 5 SMR 3 P
13. 2 0 1 1 2 1 4 5 G1200 1 0 0 3
14. 300mLX4 292617 80mLX4 1 Scholler N et al Soluble member s of the mesothelin megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc Natl Acad Sci USA 96 11531 11536 1999 2 Ordonez N G Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma Modern Pathology 16 192 197 2003 3 Bera T K et al Mesothelin is not required for normal mouse development or reproduction Mol Cell Biol 20 2902 2906 2000 4 Rump A et al Binding of ovarian cancer antigen CA125 MUC16 to mesothelin mediates cell adhesion J Biol Chem 279 9190 9198 2004 5 Robinson B W S et al Mesothelin family proteins and diagnosis of mesothelioma Lancet 362 1612 1616 2003 6 133 161 2002 7 8 Eibe stagi 2004 15 22 675 680 H R et al The role of new imaging techniques in diagnosis and ng of malignant pleural mesothelioma Current Opinion in Oncology 31 138 2003 9 Nishizono 1 et al Rapid and sensitive chemiluminescent enzyme immunoassa
15. 1 C BE 6 LEIA 1 3 3 3 8 5 9 SMR P 6 1 AMP PD chemiluminescent enzyme immunoassay E 5 S
16. G1200 2nmo1 L 0nmo1 41 mn 3 2 0 CV 6 1 0 3 o HTX01T 4 0 1 100nmo1 G1200 0 0 1nmo 1 5 0nmo1 2 0 0 nmo 1 L 3 SD 6 2
17. 1 8 6 6 56 85 5 1 2 40 1 8 2 4 1 1 I 64 7 1 1 I IV 6 9 24 35 E 4 7 4 1 SMRP 1 1 MR P
18. 1 2 50 L SMRP 4H3 2 3 5 0 L ALP SMRP OV5 6 9 3 4 x 1 1 0nmo 1 1 5mL 1 2 2nmo 1 L 1 5mLX1 3 50nmo1 L 1 5mLX1 4 100nmo1 L 1 5mLX1 4 3 x 1 1 Onmo 1 L 1 5mLX1 2 2nmo 1 L 1 5mLX1 3 100nmo 1 1 5mLX1 5
19. SMRP 20p7L 180 SMRP 2507L 2 0 L 37 10 4 SMRP SMRP SMRP 2 5 0 L 37 10
20. 100mLx6 50mLx6 AMP PD 6 1000mLx1 7 300mLx4 80mLx4 1 1 5 2 AMPPD 3 spiroadamantane 4 methoxy 4 3 phosphoryloxy pheny 1 2 dioxetane disodium salt 3 2 4 4 3 1 2 2 SMRP 2 SMRP lt 2 gt YY SMRP
21. 1 0 1 SD 6 6 1 3 0nmo 1 5 1 1 0 1 9 j WY 1 0 0 1 1 0 1 5nmo 1 5nmo 1 L 8 1 2 1 2 1 9 L 5 0nmo 3 0 1 L 3 0 E 4 2 SMR P
22. SMRP 5 0 7 7 2 19 5 1 59 24 157 8 5 oie 1 SMR P SMRP 8 6 1 240 1 SMR P 66 2 9 7 EV 56 85 F 1 8 9 7 1 1 1 0 3 4 1
23. 1 1 1 5 1 1 0 8 1 2 2 21 9 7 7 4 29 5 0 7 7 1 6 5 3 4 5 2 7 5 6 8 5 5 6 1 1 ed Peptides
24. RP SMR P 6 5 SMRP 6 6 SMRP nmolL 1000 0 57 TO 2 38 P lt 0 001 0 P lt 0 001 0 94 0 82 PO 0 74 001 0 80 Median 1 5nmol L 4 0 6 P
25. 4 1 0 5 2 1 2 3 NA A 2 3 3 4 4 ji 1 3
26. HTX01T HTX01T 2010 11 1 22200AMX00940000 1 a 3 7 i 4 I er 5
27. 6 3 0 0 096 10 10 0nmol L 12 096 0 0 096 2 1 9 3 6 Pacific Northwest Research Ins SMR P Soluble Mesothelin Rela SM RP
28. y for measuring tumor markers Clinical Chemistry 37 1639 1644 1991 TBL 03 5695 9234 FAX 0120 292 832 Applied Biosystems 2 62 5
Download Pdf Manuals
Related Search